China National Chemical Engineering Co (601117) Fair Value & Analysis
Industrials · CN · Market cap 45.9B CNY
Analysis
China National Chemical Engineering Co (601117) currently trades at ¥8.42, while our model-based Fair Value estimate is ¥19.91 — implying the stock looks roughly 136.5% undervalued today. We read business quality at 90/100 (high quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
China National Chemical Engineering Co., Ltd. engages in the chemical engineering business in China. It is involved in the contracting of construction engineering, petrochemicals, coal chemical industry, fine chemicals, pharmaceuticals, electric power, environmental ecological protection, infrastructure engineering and overseas engineering; and engineering consulting, surveying, design, construction, and project management and services. The company also engages in the provision of engineering supervision services; technology research and development and promotion of results; manufacturing and installation of complete sets of pipelines, lines and equipment; quality inspection technical services; import and export business; and machinery and equipment leasing. In addition, it is involved in investment and management of industrial equipment and infrastructure; dispatching labor personnel required for the implementation of overseas engineering projects; and sale of electrical equipment.…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.